Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry.

Jung Kwon KimSung Han KimMi Kyung SongJungnam JooSeong Il SeoCheol KwakChang Wook JeongCheryn SongEu Chang HwangIll Young SeoHakmin LeeSung-Hoo HongJae Young ParkJinsoo Chung

Published in: Cancer medicine (2019)

In the current targeted therapy era, survival of mNCCRCC is still inferior in comparison with that of mCCRCC patients. We found survival benefits in patients treated with first-line VEGF-TKIs/CN/metastasectomy, and metachronous metastasis patients.

Keyphrases

prognostic factors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
free survival
endothelial cells
lymph node metastasis